Enzon Pharmaceuticals's total assets for Q4 2025 were $42.81M, a decrease of -2.01% from the previous quarter. ENZND total liabilities were $45.34M for the fiscal quarter, a 1.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.